Takeda Pharmaceutical Co. Ltd. - Free Cash Flow To The Firm

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Free-Cash-Flow-To-The-Firm" stands at 1.04 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2022.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3564 Trillion JPY for the item "Free Cash Flow To The Firm" represents an increase of 81.95 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3564 Trillion JPY for the item "Free Cash Flow To The Firm" represents an increase of 47.80 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.04 Trillion JPY for the item "Free Cash Flow To The Firm" represents an increase of 12.52 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3105 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 0.3105 Trillion Japanese Yens.
The 3 year change is 0.1561 Trillion Japanese Yens.
The 5 year change is 0.4327 Trillion Japanese Yens.
The 10 year change is 0.9022 Trillion Japanese Yens.

The Serie's long term average value is 0.435 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 0.601 Trillion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2016, to it's latest available value, on 09/30/2025, is +1.10 Trillion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2021, to it's latest available value, on 09/30/2025, is -0.0022 Trillion.